PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD134 (OX-40), 25 μg
PE/Dazzle™ 594 anti-mouse CD138 (Syndecan-1), 100 μg
PE/Dazzle™ 594 anti-mouse CD138 (Syndecan-1), 25 μg
PE/Dazzle™ 594 anti-mouse CD150 (SLAM), 100 μg
PE/Dazzle™ 594 anti-mouse CD150 (SLAM), 25 μg
PE/Dazzle™ 594 anti-mouse CD152, 100 μg
PE/Dazzle™ 594 anti-mouse CD152, 25 μg
PE/Dazzle™ 594 anti-mouse CD155 (PVR), 100 μg
PE/Dazzle™ 594 anti-mouse CD155 (PVR), 25 μg
PE/Dazzle™ 594 anti-mouse CD16.2 (FcγRIV), 100 μg
PE/Dazzle™ 594 anti-mouse CD172a (SIRPα), 100 μg
PE/Dazzle™ 594 anti-mouse CD172a (SIRPα), 25 μg
PE/Dazzle™ 594 anti-mouse CD183 (CXCR3), 100 μg
PE/Dazzle™ 594 anti-mouse CD183 (CXCR3), 25 μg
PE/Dazzle™ 594 anti-mouse CD184 (CXCR4), 100 μg
PE/Dazzle™ 594 anti-mouse CD184 (CXCR4), 25 μg